Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 14, 2015; 21(22): 6820-6834
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6820
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6820
Figure 2 Liver biopsy of a patients with non-alcoholic steatohepatitis at baseline (A) and one year after 10 mg/d of rosuvastatin monotherapy (B) [unpublished data from personal archive].
- Citation: Athyros VG, Tziomalos K, Katsiki N, Doumas M, Karagiannis A, Mikhailidis DP. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. World J Gastroenterol 2015; 21(22): 6820-6834
- URL: https://www.wjgnet.com/1007-9327/full/v21/i22/6820.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i22.6820